Cloud-based platform provides real-time data insights for clinical trials
eClinical Insights, a leading-edge provider of cloud-based clinical trials software, announced today the launch of its eClinical Intelligence Platform. Built upon a first-in-class eClinical data hub that acquires and integrates data from any clinical system, and powered by a business analytics engine, the eClinical Insights platform delivers real-time clinical trial intelligence and workflow capabilities through a suite of cloud-based applications designed to help pharmaceutical, biotech, medical device, and contract research organizations improve the performance of their clinical trials through real-time data sharing and collaboration.
“With the average clinical trial using of 5-7 different clinical systems, one of the critical business challenges the industry faces today is turning these siloes of data into operational intelligence," said Peg Regan, President & CEO of eClinical Insights. “Our platform automatically leverages these disparate data into actionable information, and delivers it through an integrated suite of role-based applications. By eliminating operational blind spots, our technology platform empowers clinical research professionals with the visibility they need to make rapid, data-driven decisions."
The platform's open architecture includes a library of out-of-the-box interfaces to leading EDC technologies, enabling customers to leverage their existing technology investments as integrated components of the eClinical Insights platform. Delivered through a Software-as-a-Service (SaaS) subscription model, the platform includes a suite of cloud-based trial management applications that are available on per study basis, and can be turned on and off as needed, on both new and ongoing trials.
"We took a small data approach to solving a big data problem, and focused solely on the use of clinical trials data to optimize trial execution and collaboration," said Regan. "With a team that has decades of experience in clinical trials management, and unparalleled experience integrating data from EDC, IVR, ePRO, CTMS, and Central Laboratory systems, we had a unique vantage point from which to solve this challenge. We leveraged this experience in the development of a technology platform that delivers instant visibility across the diverse ecosystem of systems, service providers, and stakeholders of today's clinical trials."
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
HHS Cancels Moderna Grant for Late-Stage Development of mRNA Vaccine Candidate
June 4th 2025Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s award for almost $600 million to accelerate vaccine development will be terminated.